Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.

Press/Media

Period	Nov 4 2020

Media coverage

Title	Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.
Media name/outlet	Drug Genius
Country/Territory	United States
Date	11/4/20
URL	https://druggenius.com/clinical-trials/pembrolizumab-immunotherapy-drug-in-combination-with-guadecitabine-and-mocetinostat-epigenetic-drugs-for-patients-with-advanced-lung-cancer/
Persons	Hossein Borghaei